Evidence map›Paper›PMID 19719843›Full record

Trial reportReproductive biology and endocrinology : RB&E2009

"hCG priming" effect in controlled ovarian stimulation through a long protocol.

Panagiotis Beretsos, George A Partsinevelos, Eleni Arabatzi, Peter Drakakis, Depy Mavrogianni, Elli Anagnostou, Kostas Stefanidis, Aris Antsaklis, Dimitris Loutradis

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Reproductive biology and endocrinology : RB&E, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03423537 (A Prospective, Multicenter, Double-blind, Placebo-controlled, Phase III Clinical Study, on the Efficacy and Safety of Low-dose hCG in a Short Protocol With GnRH Agonist and Ovarian Stimulation With Recombinant FSH), which is not on this map. Cited by 13 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 4 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03423537 phase3terminatednot on this mapstarted 2018, after this paper: background citation

A Prospective, Multicenter, Double-blind, Placebo-controlled, Phase III Clinical Study, on the Efficacy and Safety of Low-dose hCG in a Short Protocol With GnRH Agonist and Ovarian Stimulation With Recombinant FSH (rFSH) During the Follicular Phase in Subfertile Women Undergoing ART

TypeinterventionalSponsorNational and Kapodistrian University of AthensRan2018 to 2019Enrolled80ConditionsHCG, IVF, Pregnancy Rates, ARTArmshCG, Placebo
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 4 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Ectopic pregnancy and failed oocyte retrieval duringWorld journal of clinical cases · 2022
    Article
  10. Review
  11. Article
  12. Human Chorionic Gonadotropin: The Pregnancy Hormone and More.International journal of molecular sciences · 2017
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Panagiotis Beretsos1st Department of Obstetrics and Gynaecology, Division of Human Reproduction, IVF Unit, Athens University Medical School, Alexandra Hospital, Athens, Greece. pberet@biol.uoa.gr
George A Partsinevelos
Eleni Arabatzi
Peter Drakakis
Depy Mavrogianni
Elli Anagnostou
Kostas Stefanidis
Aris Antsaklis
Dimitris Loutradis
Alexandra Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, it has been demonstrated that, in patients down-regulated by GnRH analogues (GnRHa), a short-term pre-treatment with recombinant LH (rLH), prior to recombinant FSH (rFSH) administration, increases the number of small antral follicle prior to FSH stimulation and the yield of normally fertilized embryos. However, no data exist in the literature regarding the potential beneficial effect of "hCG priming" in controlled ovarian hyperstimulation (COH) through a long GnRH-a protocol, which binds the same receptor (LH/hCGR), though it is a much more potent compared to LH. The primary aims of this study were to assess the effect of short-term pre-rFSH administration of hCG in women entering an ICSI treatment cycle on follicular development, quality of oocytes and early embryo development. The secondary endpoints were to record the effects on endometrial quality and pregnancy rate.

methodsPatients with a history of at least one previous unsuccessful ICSI cycle were randomly assigned into two groups to receive treatment with either a long protocol with rFSH (control group) or a long protocol with rFSH and pre-treatment with hCG (hCG group). In particular, in the latter group, a fixed 7 days course of 200 IU/day hCG was administered as soon as pituitary desensitization was confirmed.

resultsThe mean number of oocytes retrieved was not significantly different between the two treatment groups, although the percentage of mature oocytes tended to be higher but not significantly different in hCG-treated patients. The percentage of patients with more than one grade 3 embryos was higher in the pre-treatment group, which also showed a higher pregnancy rate.

conclusionAll the above clinical observations, in conjunction with previous data, suggest a point towards a beneficial "hCG priming" effect in controlled ovarian hyperstimulation through a long GnRH-a down-regulation protocol, particularly in patients with previous ART failures.

Indexed as

AdultChorionic GonadotropinClinical ProtocolsDrug Administration ScheduleEmbryo TransferFemaleFollicle Stimulating HormoneHumansMaleOvulation InductionPilot ProjectsPregnancyPregnancy RateRecombinant ProteinsSperm Injections, IntracytoplasmicChorionic GonadotropinFollicle Stimulating HormoneRecombinant Proteins

Identifiers

PMID19719843
PMCPMC2744681
OpenAlexW2162067223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.